The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Merrimack Pharmaceuticals's share price is $14.73.
Merrimack Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00. Hence, Merrimack Pharmaceuticals's PS Ratio for today is .
The historical rank and industry rank for Merrimack Pharmaceuticals's PS Ratio or its related term are showing as below:
During the past 13 years, Merrimack Pharmaceuticals's highest PS Ratio was 266.34. The lowest was 4.34. And the median was 10.96.
MACK's PS Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 8.85 * Ranked among companies with meaningful PS Ratio only.
During the past 13 years, Merrimack Pharmaceuticals's highest 3-Year average Revenue per Share Growth Rate was 52.50% per year. The lowest was -35.40% per year. And the median was 38.50% per year.
Back to Basics: PS Ratio
Merrimack Pharmaceuticals PS Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Merrimack Pharmaceuticals's PS Ratio
For the Biotechnology subindustry, Merrimack Pharmaceuticals's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Merrimack Pharmaceuticals's PS Ratio Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Merrimack Pharmaceuticals's PS Ratio distribution charts can be found below:
* The bar in red indicates where Merrimack Pharmaceuticals's PS Ratio falls into.
Merrimack Pharmaceuticals PS Ratio Calculation
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Merrimack Pharmaceuticals's Share Price of today is $14.73. Merrimack Pharmaceuticals's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Merrimack Pharmaceuticals (NAS:MACK) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
Merrimack Pharmaceuticals PS Ratio Related Terms
Thank you for viewing the detailed overview of Merrimack Pharmaceuticals's PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.
Merrimack Pharmaceuticals (Merrimack Pharmaceuticals) Business Description
Merrimack Pharmaceuticals Inc is a biotechnology company that discovers, develops, and commercializes innovative medicines that consist of novel therapeutics paired with diagnostics to treat cancer. The company's core approach to systems biology is to apply multidisciplinary capabilities to build functional and predictive computational models of biological systems, such as cell signaling networks. Merrimack also enters into third-party agreements to further process and commercialize its products.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MACK has been successfully added to your 